Literature DB >> 17687013

Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest.

Rita Marimon1, Josep Cano, Josepa Gené, Deanna A Sutton, Masako Kawasaki, Josep Guarro.   

Abstract

Sporothrix schenckii is the species responsible for sporotrichosis, a fungal infection caused by the traumatic implantation of this dimorphic fungus. Recent molecular studies have demonstrated that this species constitutes a complex of numerous phylogenetic species. Since the delineation of such species could be of extreme importance from a clinical point of view, we have studied a total of 127 isolates, most of which were received as S. schenckii, including the available type strains of species currently considered synonyms, and also some close morphological species. We have phenotypically characterized all these isolates using different culture media, growth rates at different temperatures, and numerous nutritional tests and compared their calmodulin gene sequences. The molecular analysis revealed that Sporothrix albicans, S. inflata, and S. schenckii var. luriei are species that are clearly different from S. schenckii. The combination of these phenetic and genetic approaches allowed us to propose the new species Sporothrix brasiliensis, S. globosa, and S. mexicana. The key phenotypic features for recognizing these species are the morphology of the sessile pigmented conidia, growth at 30, 35, and 37 degrees C, and the assimilation of sucrose, raffinose, and ribitol.

Entities:  

Mesh:

Year:  2007        PMID: 17687013      PMCID: PMC2045377          DOI: 10.1128/JCM.00808-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases.

Authors:  Luciana Trilles; Belkys Fernández-Torres; Márcia Dos Santos Lazéra; Bodo Wanke; Armando de Oliveira Schubach; Rodrigo de Almeida Paes; Isabel Inza; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

2.  Macrorestriction analysis of clinical and environmental isolates of Sporothrix schenckii.

Authors:  L C O'Reilly; S A Altman
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 3.  Sporothrix schenckii and related species of Ceratocystis.

Authors:  L R Travassos; K O Lloyd
Journal:  Microbiol Rev       Date:  1980-12

Review 4.  Epidemiology of sporotrichosis: a study of 304 cases in Brazil.

Authors:  Ana Cecília Michel da Rosa; Maria Lúcia Scroferneker; Rodrigo Vettorato; Roberto Lopes Gervini; Gerson Vettorato; Analupe Weber
Journal:  J Am Acad Dermatol       Date:  2005-03       Impact factor: 11.527

5.  Mitochondrial DNA analysis of Sporothrix schenckii in North and South America.

Authors:  H Ishizaki; M Kawasaki; M Aoki; T Matsumoto; A A Padhye; M Mendoza; R Negroni
Journal:  Mycopathologia       Date:  1998       Impact factor: 2.574

6.  In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.

Authors:  E M Johnson; A Szekely; D W Warnock
Journal:  J Antimicrob Chemother       Date:  1998-12       Impact factor: 5.790

7.  Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.

Authors:  Arianna Tavanti; Amanda D Davidson; Neil A R Gow; Martin C J Maiden; Frank C Odds
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

8.  Cryptic speciation in the cosmopolitan and clonal human pathogenic fungus Aspergillus fumigatus.

Authors:  A Pringle; D M Baker; J L Platt; J P Wares; J P Latgé; J W Taylor
Journal:  Evolution       Date:  2005-09       Impact factor: 3.694

9.  Analysis of restriction profiles of mitochondrial DNA from Sporothrix schenckii and related fungi.

Authors:  K Suzuki; M Kawasaki; H Ishizaki
Journal:  Mycopathologia       Date:  1988-09       Impact factor: 2.574

10.  Isolation and characterization of Sporothrix schenckii from clinical and environmental sources associated with the largest U.S. epidemic of sporotrichosis.

Authors:  D M Dixon; I F Salkin; R A Duncan; N J Hurd; J H Haines; M E Kemna; F B Coles
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

View more
  151 in total

1.  Adenosine deaminase activity in serum and lymphocytes of rats infected with Sporothrix schenckii.

Authors:  Verônica S P Castro; Victor C Pimentel; Aleksandro S Da Silva; Gustavo R Thomé; Patrícia Wolkmer; Jorge L C Castro; Márcio M Costa; Cássia B da Silva; Daniele C Oliveira; Sydney H Alves; Maria R C Schetinger; Sonia T A Lopes; Cinthia M Mazzanti
Journal:  Mycopathologia       Date:  2011-12-15       Impact factor: 2.574

2.  Disseminated Sporothrix brasiliensis infection with endocardial and ocular involvement in an HIV-infected patient.

Authors:  Mario León Silva-Vergara; Zoilo Pires de Camargo; Patricia Ferreira Silva; Michel Reis Abdalla; Ricardo Nilsson Sgarbieri; Anderson Messias Rodrigues; Keila Cristina dos Santos; Cristina Hueb Barata; Kennio Ferreira-Paim
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

3.  Rapid identification of Sporothrix species by T3B fingerprinting.

Authors:  Manoel Marques Evangelista de Oliveira; Paula Sampaio; Rodrigo Almeida-Paes; Célia Pais; Maria Clara Gutierrez-Galhardo; Rosely Maria Zancope-Oliveira
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

4.  In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.

Authors:  Yang Song; Shanshan Li; Ying Shi; Lipei Zhao; Yu Cui; Lei Yao; Yu Zhen; Ruili Chen; Yan Cui
Journal:  Braz J Microbiol       Date:  2020-06-17       Impact factor: 2.476

5.  Increase in virulence of Sporothrix brasiliensis over five years in a patient with chronic disseminated sporotrichosis.

Authors:  Dayvison F S Freitas; Suelen S Santos; Rodrigo Almeida-Paes; Manoel M E de Oliveira; Antonio C F do Valle; Maria Clara Gutierrez-Galhardo; Rosely M Zancopé-Oliveira; Joshua D Nosanchuk
Journal:  Virulence       Date:  2015       Impact factor: 5.882

6.  The use of (1-3) β-glucan along with itraconazole against canine refractory sporotrichosis.

Authors:  Karina Affeldt Guterres; Caroline Bohnen de Matos; Luiza Da Gama Osório; Isabel Duarte Schuch; Marlete Brum Cleff
Journal:  Mycopathologia       Date:  2014-03-21       Impact factor: 2.574

7.  The Upside of Bias: A Case of Chronic Meningitis Due to Sporothrix Schenckii in an Immunocompetent Host.

Authors:  Christine Hessler; Carol A Kauffman; Felicia C Chow
Journal:  Neurohospitalist       Date:  2016-04-05

8.  Phenotypic and molecular characterisation of Sporothrix globosa of diverse origin from India.

Authors:  Shivaprakash M Rudramurthy; Shamanth A Shankarnarayan; Basavaraj M Hemashetter; Santwana Verma; Smriti Chauhan; Reema Nath; Jayanthi Savio; Malini Capoor; Harsimran Kaur; Anup K Ghosh; Arunaloke Chakrabarti
Journal:  Braz J Microbiol       Date:  2020-07-30       Impact factor: 2.476

9.  Characterization of virulence profile, protein secretion and immunogenicity of different Sporothrix schenckii sensu stricto isolates compared with S. globosa and S. brasiliensis species.

Authors:  Geisa Ferreira Fernandes; Priscila Oliveira dos Santos; Anderson Messias Rodrigues; Alexandre Augusto Sasaki; Eva Burger; Zoilo Pires de Camargo
Journal:  Virulence       Date:  2013-01-16       Impact factor: 5.882

10.  Asexual propagation of a virulent clone complex in a human and feline outbreak of sporotrichosis.

Authors:  Marcus de Melo Teixeira; Anderson Messias Rodrigues; Clement K M Tsui; Luiz Gonzaga Paulo de Almeida; Anne D Van Diepeningen; Bert Gerrits van den Ende; Geisa Ferreira Fernandes; Rui Kano; Richard C Hamelin; Leila Maria Lopes-Bezerra; Ana Tereza Ribeiro Vasconcelos; Sybren de Hoog; Zoilo Pires de Camargo; Maria Sueli Soares Felipe
Journal:  Eukaryot Cell       Date:  2014-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.